
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/O-PCE: Difference between revisions
Jump to navigation
Jump to search
>BronzeManul m Replaced skeletal structure image with standardised svg image. |
>Standard Fix copy-paste error for afterglow duration |
||
(22 intermediate revisions by 5 users not shown) | |||
Line 40: | Line 40: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=O-PCE, Eticyclidone | |NameCommon=[[common name::O-PCE]], [[common name::Eticyclidone]] | ||
|NameSubstitution=2'-Oxo-PCE | |NameSubstitution=2'-Oxo-PCE | ||
|NameSystematic=2-(Ethylamino)-2-phenylcyclohexan-1-one | |NameSystematic=2-(Ethylamino)-2-phenylcyclohexan-1-one | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[Dissociative]] | |EffectClass=[[psychoactive class::Dissociative]] | ||
|ChemicalClass=[[Arylcyclohexylamine]] | |ChemicalClass=[[chemical class::Arylcyclohexylamine]] | ||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
Line 53: | Line 53: | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose::1]] | |OralROA_Threshold=[[Oral threshold dose::1]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::3]] - [[Oral max light dose::5]] mg | |OralROA_Light=[[Oral min light dose::3]] - [[Oral max light dose::5]] mg | ||
|OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | |OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::15]] mg | ||
|OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::25]] mg | |OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::25]] mg | ||
|OralROA_Heavy=[[Oral | |OralROA_Heavy=[[Oral heavy dose::25]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
Line 64: | Line 64: | ||
|OralROA_Peak= | |OralROA_Peak= | ||
|OralROA_Offset= | |OralROA_Offset= | ||
|OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max | |OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::48]] [[Oral afterglow time units::hours]] | ||
|InsufflatedROA=true | |InsufflatedROA=true | ||
Line 70: | Line 70: | ||
|InsufflatedROA_Caption= | |InsufflatedROA_Caption= | ||
|InsufflatedROA_Bioavailability= | |InsufflatedROA_Bioavailability= | ||
|InsufflatedROA_Threshold=[[Insufflated threshold dose::2]] | |InsufflatedROA_Threshold=[[Insufflated threshold dose::2]] [[Insufflated dose units::mg]] | ||
|InsufflatedROA_Light=[[Insufflated min light dose::3]] - [[Insufflated max light dose::6]] mg | |InsufflatedROA_Light=[[Insufflated min light dose::3]] - [[Insufflated max light dose::6]] mg | ||
|InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | |InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | ||
|InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | |InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | ||
|InsufflatedROA_Heavy=[[Insufflated | |InsufflatedROA_Heavy=[[Insufflated heavy dose::20]] mg + | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= | ||
|InsufflatedROA_TimelineWidth= | |InsufflatedROA_TimelineWidth= | ||
Line 81: | Line 81: | ||
|InsufflatedROA_Peak= | |InsufflatedROA_Peak= | ||
|InsufflatedROA_Offset= | |InsufflatedROA_Offset= | ||
|InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::2]] - [[Insufflated max | |InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::2]] - [[Insufflated max afterglow time::12]] [[Insufflated afterglow time units::hours]] | ||
}} | }} |
Latest revision as of 13:45, 4 June 2022
SubstanceBox/O-PCE | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||
Common names | O-PCE, Eticyclidone | ||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 2'-Oxo-PCE | ||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 2-(Ethylamino)-2-phenylcyclohexan-1-one | ||||||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||
|